Logo image of PRX.AS

PROSUS NV (PRX.AS) Stock Fundamental Analysis

Europe - AMS:PRX - NL0013654783 - Common Stock

61.57 EUR
+2.09 (+3.51%)
Last: 10/27/2025, 9:51:19 AM
Fundamental Rating

6

Overall PRX gets a fundamental rating of 6 out of 10. We evaluated PRX against 13 industry peers in the Broadline Retail industry. PRX has an excellent financial health rating, but there are some minor concerns on its profitability. PRX is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PRX suitable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PRX had positive earnings in the past year.
In the past year PRX had a positive cash flow from operations.
PRX had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: PRX reported negative operating cash flow in multiple years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

PRX's Return On Assets of 17.04% is amongst the best of the industry. PRX outperforms 92.31% of its industry peers.
PRX's Return On Equity of 24.23% is fine compared to the rest of the industry. PRX outperforms 76.92% of its industry peers.
PRX's Return On Invested Capital of 0.21% is on the low side compared to the rest of the industry. PRX is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROIC 0.21%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

With an excellent Profit Margin value of 200.44%, PRX belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
In the last couple of years the Profit Margin of PRX has grown nicely.
Looking at the Operating Margin, with a value of 3.05%, PRX is doing worse than 76.92% of the companies in the same industry.
With a Gross Margin value of 42.53%, PRX is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
PRX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRX is destroying value.
The number of shares outstanding for PRX has been reduced compared to 1 year ago.
The number of shares outstanding for PRX has been increased compared to 5 years ago.
Compared to 1 year ago, PRX has an improved debt to assets ratio.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

An Altman-Z score of 5.66 indicates that PRX is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 5.66, PRX is doing good in the industry, outperforming 69.23% of the companies in the same industry.
The Debt to FCF ratio of PRX is 9.30, which is on the high side as it means it would take PRX, 9.30 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.30, PRX is in line with its industry, outperforming 46.15% of the companies in the same industry.
PRX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.30, PRX is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 5.66
ROIC/WACC0.03
WACC6.97%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 3.54 indicates that PRX has no problem at all paying its short term obligations.
PRX has a better Current ratio (3.54) than 100.00% of its industry peers.
A Quick Ratio of 3.50 indicates that PRX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.50, PRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.54
Quick Ratio 3.5
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.26% over the past year.
PRX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.24% yearly.
Looking at the last year, PRX shows a quite strong growth in Revenue. The Revenue has grown by 12.86% in the last year.
The Revenue has been growing by 13.13% on average over the past years. This is quite good.
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%

3.2 Future

The Earnings Per Share is expected to grow by 16.83% on average over the next years. This is quite good.
The Revenue is expected to grow by 15.83% on average over the next years. This is quite good.
EPS Next Y23.15%
EPS Next 2Y18.93%
EPS Next 3Y16.83%
EPS Next 5YN/A
Revenue Next Year22.94%
Revenue Next 2Y18.42%
Revenue Next 3Y15.83%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.84, PRX is valued correctly.
PRX's Price/Earnings ratio is rather cheap when compared to the industry. PRX is cheaper than 92.31% of the companies in the same industry.
When comparing the Price/Earnings ratio of PRX to the average of the S&P500 Index (26.89), we can say PRX is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 17.67, the valuation of PRX can be described as rather expensive.
Based on the Price/Forward Earnings ratio, PRX is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.99. PRX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.84
Fwd PE 17.67
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

69.23% of the companies in the same industry are cheaper than PRX, based on the Enterprise Value to EBITDA ratio.
PRX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 96.26
EV/EBITDA 448.43
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PRX's earnings are expected to grow with 16.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.6
PEG (5Y)0.8
EPS Next 2Y18.93%
EPS Next 3Y16.83%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.34%, PRX is not a good candidate for dividend investing.
PRX's Dividend Yield is a higher than the industry average which is at 1.18.
Compared to an average S&P500 Dividend Yield of 2.31, PRX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.34%

5.2 History

The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

PRX pays out 2.17% of its income as dividend. This is a sustainable payout ratio.
DP2.17%
EPS Next 2Y18.93%
EPS Next 3Y16.83%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

PROSUS NV

AMS:PRX (10/27/2025, 9:51:19 AM)

61.57

+2.09 (+3.51%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)06-23 2025-06-23/amc
Earnings (Next)11-24 2025-11-24
Inst Owners64.41%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner ChangeN/A
Market Cap146.47B
Revenue(TTM)6.17B
Net Income(TTM)12.37B
Analysts78.26
Price Target62.45 (1.43%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.34%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.38%
PT rev (3m)10.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)9.51%
Valuation
Industry RankSector Rank
PE 13.84
Fwd PE 17.67
P/S 27.57
P/FCF 96.26
P/OCF 90.81
P/B 3.33
P/tB 3.44
EV/EBITDA 448.43
EPS(TTM)4.45
EY7.23%
EPS(NY)3.48
Fwd EY5.66%
FCF(TTM)0.64
FCFY1.04%
OCF(TTM)0.68
OCFY1.1%
SpS2.23
BVpS18.48
TBVpS17.92
PEG (NY)0.6
PEG (5Y)0.8
Graham Number43.01
Profitability
Industry RankSector Rank
ROA 17.04%
ROE 24.23%
ROCE 0.28%
ROIC 0.21%
ROICexc 0.3%
ROICexgc 0.31%
OM 3.05%
PM (TTM) 200.44%
GM 42.53%
FCFM 28.64%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 45.16
Cap/Depr 72.6%
Cap/Sales 1.72%
Interest Coverage 0.36
Cash Conversion 560.78%
Profit Quality 14.29%
Current Ratio 3.54
Quick Ratio 3.5
Altman-Z 5.66
F-Score6
WACC6.97%
ROIC/WACC0.03
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.26%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%161.96%
EPS Next Y23.15%
EPS Next 2Y18.93%
EPS Next 3Y16.83%
EPS Next 5YN/A
Revenue 1Y (TTM)12.86%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%10.17%
Revenue Next Year22.94%
Revenue Next 2Y18.42%
Revenue Next 3Y15.83%
Revenue Next 5YN/A
EBIT growth 1Y212.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year328.77%
EBIT Next 3Y94.96%
EBIT Next 5YN/A
FCF growth 1Y181.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y169.5%
OCF growth 3YN/A
OCF growth 5YN/A

PROSUS NV / PRX.AS FAQ

Can you provide the ChartMill fundamental rating for PROSUS NV?

ChartMill assigns a fundamental rating of 6 / 10 to PRX.AS.


What is the valuation status for PRX stock?

ChartMill assigns a valuation rating of 5 / 10 to PROSUS NV (PRX.AS). This can be considered as Fairly Valued.


What is the profitability of PRX stock?

PROSUS NV (PRX.AS) has a profitability rating of 5 / 10.


Can you provide the financial health for PRX stock?

The financial health rating of PROSUS NV (PRX.AS) is 7 / 10.


Can you provide the expected EPS growth for PRX stock?

The Earnings per Share (EPS) of PROSUS NV (PRX.AS) is expected to grow by 23.15% in the next year.